Lung Cancer · 2017 · 39 citations · 29 references
MedicineMolecular GeneticsOncologyMolecular OncologyNeoplasiaOncogenesCancer Cell SignalingDeath ReceptorsLung CancerMolecular Tumor ProfilingOncogenic Signaling PathwaysSignal Transduction In CancerEgfr Mutation TestingProgrammed Cell Death Ligand 1 RegulationProgrammed Death-ligand 1 BiomarkerProgrammed Death-ligand 1 SignalingProgrammed Death-ligand 1 Upregulation
29
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +15